Literature DB >> 3099362

Bone and joint infections in intravenous drug abusers.

P H Chandrasekar, A P Narula.   

Abstract

An analysis of data on 45 intravenous drug abusers treated for skeletal infection in 1982-1983 is presented. Eighty percent of patients were younger than 40 years old. None had any serious underlying illnesses. Septic arthritis was noted in 33 patients, osteomyelitis in seven, and both in five. Bone or joint infection involved the extremities in 78% of patients. The knee joint (left, 11 patients; right, four) was most commonly affected, and the left groin was the most frequent site of drug injections, a finding that suggests a relationship between the sites of injection and infection. Fever was absent in 16 (36%) of 45 patients. The predominant pathogens isolated were methicillin-resistant Staphylococcus aureus and groups A and G streptococci. Pseudomonas aeruginosa was much less common (11% of patients). Treatment included bed rest, intravenous antibiotics, and arthrocentesis when needed. Surgery was required in only seven (16%) of 45 patients. The immediate prognosis for intravenous drug abusers with skeletal infection was excellent. Attempts to obtain follow-up information from most patients, however, were unsuccessful.

Entities:  

Mesh:

Year:  1986        PMID: 3099362     DOI: 10.1093/clinids/8.6.904

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  16 in total

1.  Microbiology of bone and joint infections in injecting drug abusers.

Authors:  Daniel C Allison; Paul D Holtom; Michael J Patzakis; Charalampos G Zalavras
Journal:  Clin Orthop Relat Res       Date:  2010-08       Impact factor: 4.176

2.  Using Population Based Hospitalization Data to Monitor Increases in Conditions Causing Morbidity Among Persons Who Inject Drugs.

Authors:  Melissa G Collier; Mona Doshani; Alice Asher
Journal:  J Community Health       Date:  2018-06

Review 3.  Medical complications of intravenous drug use.

Authors:  M D Stein
Journal:  J Gen Intern Med       Date:  1990 May-Jun       Impact factor: 5.128

4.  Subacute knee pain and swelling in a healthy male: a case of Brodie's abscess.

Authors:  Mitesh K Patel; Steven Barrientos; Sunny Gupta; Bradford Tucker
Journal:  BMJ Case Rep       Date:  2019-03-20

5.  Total knee arthroplasty in patients with a history of illicit intravenous drug abuse.

Authors:  David E Bauer; Andreas Hingsammer; Lukas Ernstbrunner; Alexander Aichmair; Andrea B Rosskopf; Franziska Eckers; Karl Wieser; Sandro F Fucentese
Journal:  Int Orthop       Date:  2017-10-14       Impact factor: 3.075

6.  Two cases of osteomyelitis due to group G streptococcus.

Authors:  N Joshi; J N Goldman
Journal:  Can J Infect Dis       Date:  1990

7.  Osteoarticular infection in intravenous drug abusers: influence of HIV infection and differences with non drug abusers.

Authors:  S Muñoz-Fernández; M A Maciá; L Pantoja; A Cardenal; J M Peña; E Martín Mola; A Balsa; F J Barbado; J J Vázquez; J Gijón Baños
Journal:  Ann Rheum Dis       Date:  1993-08       Impact factor: 19.103

8.  A prospective study of the incidence and characteristics of septic arthritis in a teaching hospital in Riyadh, Saudi Arabia.

Authors:  Abdurahman Saud Al Arfaj
Journal:  Clin Rheumatol       Date:  2008-06-27       Impact factor: 2.980

9.  [Bacterial osteitis. Special considerations in immunocompromised patients].

Authors:  C Niedhart; O Miltner; K-W Zilkens; F U Niethard
Journal:  Orthopade       Date:  2004-03       Impact factor: 1.087

10.  A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a).

Authors:  Ellen Jo Baron; J Michael Miller; Melvin P Weinstein; Sandra S Richter; Peter H Gilligan; Richard B Thomson; Paul Bourbeau; Karen C Carroll; Sue C Kehl; W Michael Dunne; Barbara Robinson-Dunn; Joseph D Schwartzman; Kimberle C Chapin; James W Snyder; Betty A Forbes; Robin Patel; Jon E Rosenblatt; Bobbi S Pritt
Journal:  Clin Infect Dis       Date:  2013-07-10       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.